Skip to main content
All lobbying filings

SHIONOGI INC.

Lobbying for SHIONOGI INC. · Pharmaceutical company

 Filing 1st Quarter - Report
Reporting period
1st Quarter 2026
Jan 1 - Mar 31 · Posted Apr 18, 2026
Expenses
$110,000.00
What this organization spent lobbying with its own staff. Reported using A: the three LDA methods count different costs, so an expenses figure is not comparable across filers that used different ones.
Client based in
New Jersey

Official filing document

 Government bodies contacted 2
  • HOUSE OF REPRESENTATIVES
  • SENATE

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when.

 Bills named in this filing 2
 Lobbying activity 7
Budget/Appropriations

Pandemic preparedness, Antimicrobial resistance, PASTEUR Act (H.R. 3932 AND s. 2076)

Health Issues

Pandemic preparedness, Antimicrobial resistance, PASTEUR Act (H.R. 3932 AND s. 2076)

Medical/Disease Research/Clinical Labs

Pandemic preparedness, Antimicrobial resistance, PASTEUR Act (H.R. 3932 AND s. 2076)

Insurance

Pandemic preparedness, Antimicrobial resistance, PASTEUR Act (H.R. 3932 AND s. 2076)

Medicare/Medicaid

Pandemic preparedness, Antimicrobial resistance, PASTEUR Act (H.R. 3932 AND s. 2076)

Pharmacy

Pandemic preparedness, Antimicrobial resistance, PASTEUR Act (H.R. 3932 AND s. 2076)

Science/Technology

Pandemic preparedness, Antimicrobial resistance, PASTEUR Act (H.R. 3932 AND s. 2076)

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.

Report a problem